The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Humulin I (Isophane) 100 IU/ml Suspension for Injection in vial

100 international unit(s)/millilitre Suspension for injection

Eli Lilly Nederland B.V.PA2276/002/003

Main Information

Trade NameHumulin I (Isophane) 100 IU/ml Suspension for Injection in vial
Active SubstancesHuman insulin (recombinant dna origin)
Strength100 international unit(s)/millilitre
Dosage FormSuspension for injection
Licence HolderEli Lilly Nederland B.V.
Licence NumberPA2276/002/003

Group Information

ATC CodeA10AC Insulins and analogues for injection, intermediate-acting
A10AC01 insulin (human)


Licence Issued13/03/2015
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back